The company said the discontinuation was due to several reasons,” Reuters news service reported, “including limited interest ...

Discover how hemophilia A affects blood clotting, its genetic patterns, warning signs, advanced treatment options, and ...

Alfred E. Mann Charities has made a generous gift of $12 million to establish the Alfred E. Mann Cell and Gene Therapy ...

The UNC technology, developed by Pediatrics Professor Chengwen Li, M.D., Ph.D., uses adeno-associated viruses (AAVs) to ferry ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

India has launched its first human gene therapy for hemophilia, showing progress in biotech-led healthcare innovation.

Single-Dose Gene Therapy Is Potentially Life-Changing for Adults With Hemophilia B Sep. 25, 2024 — Adults with hemophilia B saw their number of bleeding episodes drop by an average of 71 percent ...

After a patient died following a high dose of Neurogene’s Rett syndrome gene therapy candidate, the biotech is sharing ...

Bayer’s Jivi is a factor VIII replacement therapy that has been engineered with a compound that allows for less frequent dosing. It is now indicated for patients 7 years of age and older.